Bluetongue illness at present noticeable to the World Organization for Animal Health (OIE); causes huge financial losses on account of fast deteriorate commerce related to bluetongue outbreaks and excessive mortality and morbidity.The capsid coat protein of Bluetongue virus(BTV)VP2 is answerable for BTV transmission by the Culicoides vector to vertebrate hosts throughout blood feeding.
7 polypeptides have been discovered to be current within the capsid of the BTV, 4 of that are main and three are minor parts. Besides, VP2 is answerable for BTV entry into permissive cells and therefore performs a serious function in illness development.
However, its mechanism of motion just isn’t recognized until date.The current investigation aimed to foretell the 3D construction of Viral Protein 2 of bluetongue virus adopted by Structure validation, Molecular Dynamics simulation and lively website prediction.The In silico method offers a platform for figuring out the construction of the VP2 protein. The 3D construction of VP2 protein was constructed utilizing a Python-based Computational algorithm. The templates had been recognized utilizing Smith waterman’s Local alignment. The VP2 protein construction validated utilizing PROCHECK and offered utilizing Ramachandran plots.
Molecular Dynamics Simulation (MDS) research had been carried out utilizing an educational software program Desmond, Schrodinger dynamics for figuring out the steadiness of mannequin protein. The Ligand – Binding website was predicted by a homology looking out by construction comparability and protein-protein in networks evaluation, to reveals their stability and inhibition mechanism adopted by lively website identification.
The secondary construction of the mannequin concluded that the mannequin incorporates 220 Alpha Helix atoms, 403 10Helix, 151 Beta sheets, 134 coils and 424 turns whereas the 3D construction of Viral Protein 2 of BTV discovered to have 15774 complete atoms within the construction.961 amino acids had been discovered the ultimate mannequin.
 EIF4E |
|
MBS8564102-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 565 |
EIF4E |
|
MBS8564102-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 565 |
EIF4E |
|
MBS8564102-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 565 |
EIF4E |
|
MBS8564102-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 565 |
 EIF4E siRNA |
|
20-abx915211 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
EIF4E siRNA |
|
20-abx915212 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
EIF4E siRNA |
|
20-abx901689 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
 EIF4E antibody |
|
10R-11030 |
Fitzgerald |
100 ug |
EUR 344 |
|
|
|
Description: Mouse monoclonal EIF4E antibody |
EIF4E antibody |
|
10R-3955 |
Fitzgerald |
100 ul |
EUR 709 |
|
|
|
Description: Mouse monoclonal EIF4E antibody |
EIF4E antibody |
|
10R-3956 |
Fitzgerald |
100 ul |
EUR 709 |
|
|
|
Description: Mouse monoclonal EIF4E antibody |
EIF4E antibody |
|
10R-3957 |
Fitzgerald |
100 ul |
EUR 709 |
|
|
|
Description: Mouse monoclonal EIF4E antibody |
EIF4E antibody |
|
10R-6905 |
Fitzgerald |
100 ul |
EUR 709 |
|
|
|
Description: Mouse monoclonal EIF4E antibody |
 eIF4E antibody |
|
20R-2389 |
Fitzgerald |
50 ug |
EUR 269 |
|
|
|
Description: Rabbit polyclonal eIF4E antibody |
eIF4E antibody |
|
20R-2073 |
Fitzgerald |
50 ug |
EUR 269 |
|
|
|
Description: Rabbit polyclonal eIF4E antibody |
 EIF4E Antibody |
|
32632-100ul |
SAB |
100ul |
EUR 302.4 |
EIF4E Antibody |
|
E10-30189 |
EnoGene |
100μg/100μl |
EUR 225 |
|
Description: Available in various conjugation types. |
 eIF4E Antibody |
|
E18-6110-1 |
EnoGene |
50μg/50μl |
EUR 145 |
|
Description: Available in various conjugation types. |
eIF4E Antibody |
|
E18-6110-2 |
EnoGene |
100μg/100μl |
EUR 225 |
|
Description: Available in various conjugation types. |
EIF4E Antibody |
|
E19-6885 |
EnoGene |
100μg/100μl |
EUR 225 |
|
Description: Available in various conjugation types. |
EIF4E Antibody |
|
E92162 |
EnoGene |
100ul |
EUR 255 |
|
Description: Available in various conjugation types. |
EIF4E Antibody |
|
E38PA1378 |
EnoGene |
100ul |
EUR 225 |
|
Description: Available in various conjugation types. |
EIF4E Antibody |
|
E300116 |
EnoGene |
100ug/200ul |
EUR 275 |
|
Description: Available in various conjugation types. |
EIF4E Antibody |
|
E312256 |
EnoGene |
200ul |
EUR 275 |
|
Description: Available in various conjugation types. |
eIF4E Antibody |
|
E2220030 |
EnoGene |
100ug |
EUR 225 |
|
Description: Available in various conjugation types. |
EIF4E antibody |
|
70R-4682 |
Fitzgerald |
50 ug |
EUR 467 |
|
|
|
Description: Rabbit polyclonal EIF4E antibody raised against the C terminal of EIF4E |
 Eif4e antibody |
|
70R-9620 |
Fitzgerald |
50 ug |
EUR 467 |
|
|
|
Description: Affinity purified rabbit polyclonal Eif4e antibody |
EIF4E antibody |
|
70R-49697 |
Fitzgerald |
100 ul |
EUR 242 |
|
|
|
Description: Purified Polyclonal EIF4E antibody |
EIF4E Antibody |
|
1-CSB-PA007556GA01HU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: A polyclonal antibody against EIF4E. Recognizes EIF4E from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF |
EIF4E Antibody |
|
1-CSB-PA007556LA01HU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: A polyclonal antibody against EIF4E. Recognizes EIF4E from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200 |
EIF4E Antibody |
|
1-CSB-PA002308 |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: A polyclonal antibody against EIF4E. Recognizes EIF4E from Human, Mouse, Rat, Monkey. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/10000 |
EIF4E Antibody |
|
F47410-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
|
|
|
Description: eIF4F is a multi-subunit complex, the composition of which varies with external and internal environmental conditions. It is composed of at least EIF4A, EIF4E and EIF4G1/EIF4G3. EIF4E is also known to interact with other partners. The interaction with EIF4ENIF1 mediates the import into the nucleus. Nonphosphorylated EIF4EBP1, EIF4EBP2 and EIF4EBP3 compete with EIF4G1/EIF4G3 to interact with EIF4E; insulin stimulated MAP-kinase (MAPK1 and MAPK3) phosphorylation of EIF4EBP1 causes dissociation of the complex allowing EIF4G1/EIF4G3 to bind and consequent initiation of translation. Rapamycin can attenuate insulin stimulation, mediated by FKBPs. this gene also interacts mutually exclusive with EIF4A1 and EIF4A2. |
EIF4E Antibody |
|
F47410-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
|
|
|
Description: eIF4F is a multi-subunit complex, the composition of which varies with external and internal environmental conditions. It is composed of at least EIF4A, EIF4E and EIF4G1/EIF4G3. EIF4E is also known to interact with other partners. The interaction with EIF4ENIF1 mediates the import into the nucleus. Nonphosphorylated EIF4EBP1, EIF4EBP2 and EIF4EBP3 compete with EIF4G1/EIF4G3 to interact with EIF4E; insulin stimulated MAP-kinase (MAPK1 and MAPK3) phosphorylation of EIF4EBP1 causes dissociation of the complex allowing EIF4G1/EIF4G3 to bind and consequent initiation of translation. Rapamycin can attenuate insulin stimulation, mediated by FKBPs. this gene also interacts mutually exclusive with EIF4A1 and EIF4A2. |
EIF4E Antibody |
|
F47411-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
|
|
|
Description: EIF4E is a eukaryotic translation initiation factor involved in directing ribosomes to the cap structure of mRNAs. It is a 27-kD polypeptide that exists as both a free form and as part of a multiprotein complex termed EIF4F. The EIF4E polypeptide is the rate-limiting component of the eukaryotic translation apparatus and is involved in the mRNA-ribosome binding step of eukaryotic protein synthesis. The other subunits of EIF4F are a 50-kD polypeptide, termed EIF4A (see MIM 601102), that possesses ATPase and RNA helicase activities, and a 220-kD polypeptide, EIF4G. |
EIF4E Antibody |
|
F47411-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
|
|
|
Description: EIF4E is a eukaryotic translation initiation factor involved in directing ribosomes to the cap structure of mRNAs. It is a 27-kD polypeptide that exists as both a free form and as part of a multiprotein complex termed EIF4F. The EIF4E polypeptide is the rate-limiting component of the eukaryotic translation apparatus and is involved in the mRNA-ribosome binding step of eukaryotic protein synthesis. The other subunits of EIF4F are a 50-kD polypeptide, termed EIF4A (see MIM 601102), that possesses ATPase and RNA helicase activities, and a 220-kD polypeptide, EIF4G. |
EIF4E Antibody |
|
F40229-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
|
|
|
Description: EIF4E recognizes and binds the 7-methylguanosine-containing mRNA cap during an early step in the initiation of protein synthesis and facilitates ribosome binding by inducing the unwinding of the mRNAs secondary structures. |
EIF4E Antibody |
|
F40229-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 330.65 |
|
|
|
Description: EIF4E recognizes and binds the 7-methylguanosine-containing mRNA cap during an early step in the initiation of protein synthesis and facilitates ribosome binding by inducing the unwinding of the mRNAs secondary structures. |
EIF4E Antibody |
|
F53514-0.1ML |
NSJ Bioreagents |
0.1 ml |
EUR 330.65 |
|
|
|
Description: EIF4E recognizes and binds the 7-methylguanosine-containing mRNA cap during an early step in the initiation of protein synthesis and facilitates ribosome binding by inducing the unwinding of the mRNAs secondary structures. |
EIF4E Antibody |
|
F54054-0.1ML |
NSJ Bioreagents |
0.1 ml |
EUR 322.15 |
|
|
|
Description: Recognizes and binds the 7-methylguanosine-containing mRNA cap during an early step in the initiation of protein synthesis and facilitates ribosome binding by inducing the unwinding of the mRNAs secondary structures. Component of the CYFIP1-EIF4E-FMR1 complex which binds to the mRNA cap and mediates translational repression. In the CYFIP1-EIF4E-FMR1 complex this subunit mediates the binding to the mRNA cap. [UniProt] |
EIF4E Antibody |
|
RQ5157 |
NSJ Bioreagents |
100ul |
EUR 356.15 |
|
|
|
Description: eIF4E, a protein modulates translation of maternal mRNAs in early embryos before the onset of zygotic transcription. eIF4E also influences the overall rate of translation. eIF4E binds to the 7 methyl GTP cap structure of eukaryotic mRNAs. Phosphorylation of eIF4E on serine 209 regulates the affinity of this protein for the 7 methyl GTP cap and/or RNA. Phosphorylation also enhances the interaction of eIF4E with eIF4G, which form a complex known as eIF4F. eIF4E phosphorylation is correlated with increased translational rate in a number of cell types. |
EIF4E Antibody |
|
V9192-100UG |
NSJ Bioreagents |
100ug |
EUR 349.3 |
|
|
|
Description: The initiation of protein synthesis in eukaryotic cells is regulated by interactions between protein initiation factors and RNA molecules. The eukaryotic initiation complex eIF4F exists in vitro as a trimeric complex of eIF4E, eIF4A and eIF4G. Together, the complex allows ribosome binding to mRNA by inducing the unwinding of mRNA secondary structures. eIF4E binds to the mRNA cap during an early step in the initiation of protein synthesis. eIF4A acts as an ATP-dependent RNA helicase. eIF4G acts as a bridge between eIF4E, eIF4A and the eIF3 complex. |
EIF4E Antibody |
|
V9192-20UG |
NSJ Bioreagents |
20ug |
EUR 153.3 |
|
|
|
Description: The initiation of protein synthesis in eukaryotic cells is regulated by interactions between protein initiation factors and RNA molecules. The eukaryotic initiation complex eIF4F exists in vitro as a trimeric complex of eIF4E, eIF4A and eIF4G. Together, the complex allows ribosome binding to mRNA by inducing the unwinding of mRNA secondary structures. eIF4E binds to the mRNA cap during an early step in the initiation of protein synthesis. eIF4A acts as an ATP-dependent RNA helicase. eIF4G acts as a bridge between eIF4E, eIF4A and the eIF3 complex. |
EIF4E Antibody |
|
V9192SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 349.3 |
|
|
|
Description: The initiation of protein synthesis in eukaryotic cells is regulated by interactions between protein initiation factors and RNA molecules. The eukaryotic initiation complex eIF4F exists in vitro as a trimeric complex of eIF4E, eIF4A and eIF4G. Together, the complex allows ribosome binding to mRNA by inducing the unwinding of mRNA secondary structures. eIF4E binds to the mRNA cap during an early step in the initiation of protein synthesis. eIF4A acts as an ATP-dependent RNA helicase. eIF4G acts as a bridge between eIF4E, eIF4A and the eIF3 complex. |
EIF4E Antibody |
|
MBS7048089-005mg |
MyBiosource |
0.05mg |
EUR 190 |
EIF4E Antibody |
|
MBS7048089-01mg |
MyBiosource |
0.1mg |
EUR 270 |
EIF4E Antibody |
|
MBS7048089-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1205 |
EIF4E Antibody |
|
MBS7116282-005mg |
MyBiosource |
0.05mg |
EUR 150 |
EIF4E Antibody |
|
MBS7116282-01mg |
MyBiosource |
0.1mg |
EUR 190 |
EIF4E Antibody |
|
MBS7116282-5x01mg |
MyBiosource |
5x0.1mg |
EUR 845 |
EIF4E Antibody |
|
MBS9406517-005mL |
MyBiosource |
0.05mL |
EUR 300 |
EIF4E Antibody |
|
MBS9406517-01mL |
MyBiosource |
0.1mL |
EUR 390 |
EIF4E Antibody |
|
MBS9406517-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1610 |
EIF4E Antibody |
|
MBS859292-01mg |
MyBiosource |
0.1mg |
EUR 345 |
EIF4E Antibody |
|
MBS859292-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 565 |
EIF4E Antibody |
|
MBS859292-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 565 |
EIF4E Antibody |
|
MBS859292-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 565 |
EIF4E Antibody |
|
MBS859292-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 565 |
EIF4E Antibody |
|
MBS9207253-008mL |
MyBiosource |
0.08mL |
EUR 210 |
EIF4E Antibody |
|
MBS9207253-04mL |
MyBiosource |
0.4mL |
EUR 430 |
EIF4E Antibody |
|
MBS9207253-5x04mL |
MyBiosource |
5x0.4mL |
EUR 1910 |
EIF4E Antibody |
|
MBS9200663-008mL |
MyBiosource |
0.08mL |
EUR 210 |
EIF4E Antibody |
|
MBS9200663-04mL |
MyBiosource |
0.4mL |
EUR 430 |
EIF4E Antibody |
|
MBS9200663-5x04mL |
MyBiosource |
5x0.4mL |
EUR 1910 |
EIF4E Antibody |
|
MBS8580548-01mL |
MyBiosource |
0.1mL |
EUR 305 |
EIF4E Antibody |
|
MBS8580548-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 465 |
EIF4E Antibody |
|
MBS8580548-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 465 |
EIF4E Antibody |
|
MBS8580548-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 465 |
EIF4E Antibody |
|
MBS8580548-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 465 |
EIF4E antibody |
|
MBS831539-01mL |
MyBiosource |
0.1mL |
EUR 1095 |
EIF4E antibody |
|
MBS831539-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4770 |
EIF4E antibody |
|
MBS831886-01mL |
MyBiosource |
0.1mL |
EUR 1095 |
EIF4E antibody |
|
MBS831886-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4770 |
EIF4E Antibody |
|
MBS850484-01mg |
MyBiosource |
0.1mg |
EUR 305 |
EIF4E Antibody |
|
MBS850484-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 565 |
EIF4E Antibody |
|
MBS850484-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 565 |
EIF4E Antibody |
|
MBS850484-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 565 |
EIF4E Antibody |
|
MBS850484-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 565 |
eIF4E Antibody |
|
MBS8512196-005mg |
MyBiosource |
0.05mg |
EUR 235 |
eIF4E Antibody |
|
MBS8512196-01mg |
MyBiosource |
0.1mg |
EUR 305 |
eIF4E Antibody |
|
MBS8512196-01mLAF405M |
MyBiosource |
0.1mL(AF405M) |
EUR 465 |
eIF4E Antibody |
|
MBS8512196-01mLAF546 |
MyBiosource |
0.1mL(AF546) |
EUR 465 |
eIF4E Antibody |
|
MBS8512196-01mLAF750 |
MyBiosource |
0.1mL(AF750) |
EUR 465 |
EIF4E Antibody |
|
MBS8516355-01mg |
MyBiosource |
0.1mg |
EUR 305 |
EIF4E Antibody |
|
MBS8516355-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 465 |
EIF4E Antibody |
|
MBS8516355-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 465 |
EIF4E Antibody |
|
MBS8516355-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 465 |
EIF4E Antibody |
|
MBS8516355-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 465 |
EIF4E Antibody |
|
MBS8501121-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 565 |
EIF4E Antibody |
|
MBS8501121-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 565 |
EIF4E Antibody |
|
MBS8501121-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 565 |
EIF4E antibody |
|
MBS830639-01mL |
MyBiosource |
0.1mL |
EUR 1095 |
EIF4E antibody |
|
MBS830639-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4770 |
EIF4E Antibody |
|
MBS8501121-01mL |
MyBiosource |
0.1mL |
EUR 325 |
EIF4E Antibody |
|
MBS8501121-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 565 |
eIF4E Antibody |
|
MBS8500983-01mg |
MyBiosource |
0.1mg |
EUR 305 |
eIF4E Antibody |
|
MBS8500983-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 565 |
eIF4E Antibody |
|
MBS8500983-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 565 |
eIF4E Antibody |
|
MBS8500983-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 565 |
eIF4E Antibody |
|
MBS8500983-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 565 |
EIF4E Antibody |
|
MBS2523706-006mL |
MyBiosource |
0.06mL |
EUR 190 |
EIF4E Antibody |
|
MBS2523706-012mL |
MyBiosource |
0.12mL |
EUR 265 |
EIF4E Antibody |
|
MBS2523706-02mL |
MyBiosource |
0.2mL |
EUR 415 |
EIF4E Antibody |
|
MBS2523706-5x02mL |
MyBiosource |
5x0.2mL |
EUR 1835 |
EIF4E Antibody |
|
MBS5314317-01mL |
MyBiosource |
0.1mL |
EUR 470 |
EIF4E Antibody |
|
MBS5314317-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1955 |
EIF4E antibody |
|
MBS5309464-01mL |
MyBiosource |
0.1mL |
EUR 1095 |
EIF4E antibody |
|
MBS5309464-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4770 |
eIF4E antibody |
|
MBS5309586-005mg |
MyBiosource |
0.05mg |
EUR 485 |
eIF4E antibody |
|
MBS5309586-5x005mg |
MyBiosource |
5x0.05mg |
EUR 2045 |
eIF4E antibody |
|
MBS5309768-005mg |
MyBiosource |
0.05mg |
EUR 485 |
eIF4E antibody |
|
MBS5309768-5x005mg |
MyBiosource |
5x0.05mg |
EUR 2045 |
EIF4E Antibody |
|
MBS9601736-01mL |
MyBiosource |
0.1mL |
EUR 260 |
EIF4E Antibody |
|
MBS9601736-02mL |
MyBiosource |
0.2mL |
EUR 305 |
EIF4E Antibody |
|
MBS9601736-5x02mL |
MyBiosource |
5x0.2mL |
EUR 1220 |
EIF4E Antibody |
|
MBS9602521-005mL |
MyBiosource |
0.05mL |
EUR 260 |
EIF4E Antibody |
|
MBS9602521-01mL |
MyBiosource |
0.1mL |
EUR 325 |
EIF4E Antibody |
|
MBS9602521-02mL |
MyBiosource |
0.2mL |
EUR 400 |
EIF4E Antibody |
|
MBS9602521-5x02mL |
MyBiosource |
5x0.2mL |
EUR 1750 |
eIF4E Antibody |
|
MBS9610990-005mL |
MyBiosource |
0.05mL |
EUR 245 |
eIF4E Antibody |
|
MBS9610990-01mL |
MyBiosource |
0.1mL |
EUR 305 |
eIF4E Antibody |
|
MBS9610990-02mL |
MyBiosource |
0.2mL |
EUR 365 |
eIF4E Antibody |
|
MBS9610990-5x02mL |
MyBiosource |
5x0.2mL |
EUR 1495 |
eIF4E Antibody |
|
MBS9613762-01mL |
MyBiosource |
0.1mL |
EUR 260 |
eIF4E Antibody |
|
MBS9613762-02mL |
MyBiosource |
0.2mL |
EUR 305 |
eIF4E Antibody |
|
MBS9613762-5x02mL |
MyBiosource |
5x0.2mL |
EUR 1220 |
EIF4E Antibody |
|
MBS9607538-01mL |
MyBiosource |
0.1mL |
EUR 260 |
EIF4E Antibody |
|
MBS9607538-02mL |
MyBiosource |
0.2mL |
EUR 305 |
EIF4E Antibody |
|
MBS9607538-5x02mL |
MyBiosource |
5x0.2mL |
EUR 1220 |
eIF4E Antibody |
|
MBS9504119-005mL |
MyBiosource |
0.05mL |
EUR 285 |
eIF4E Antibody |
|
MBS9504119-01mL |
MyBiosource |
0.1mL |
EUR 385 |
eIF4E Antibody |
|
MBS9504119-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1590 |
eIF4E Antibody |
|
B7067-100ul |
Assay Biotech |
100μl |
EUR 217 |
|
Description: eIF4E Rabbit Polyclonal Antibody |
eIF4E Antibody |
|
B7067-50ul |
Assay Biotech |
50μl |
EUR 143.5 |
|
Description: eIF4E Rabbit Polyclonal Antibody |
eIF4E Antibody |
|
PHY6313A |
PhytoAB |
150 μg |
EUR 318 |
 eIF4E-IN-3 |
|
MBS5800494-5x5mg |
MyBiosource |
5x5(mg |
EUR 3970 |
 eIF4E-IN-1 |
|
MBS5800495-5x5mg |
MyBiosource |
5x5(mg |
EUR 3970 |
 eIF4E-IN-2 |
|
MBS5800498-5x5mg |
MyBiosource |
5x5(mg |
EUR 3970 |
 eIF4E-IN-6 |
|
HY-155337 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: eIF4E-IN-6(compound 4b) is a GMP analogs synthesized to targeteIF4Eand restrain its binding to cap mRNA.eIF4E-IN-6shows cell cytotoxicity against Caco-2, HepG-2,and MCF-7 cells, withIC50values of 31, 27, and 21 μM, respectively[1]. |
 eIF4E-IN-5 |
|
HY-155676 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: eIF4E-IN-5 (Compound 6n) is a eIF4E cell-permeable inhibitor. eIF4E-IN-5 can bind to capped mRNA to inhibit cap-dependent translation[1]. |
eIF4E-IN-2 |
|
HY-145262 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: eIF4E-IN-2 is a potent inhibitor of eukaryotic initiation factor 4e (eIF4e). eIF4E-IN-2 has the potential for researching eIF4e dependent diseases, including the research of cancer (extracted from patent WO2021003157A1, compound 1188)[1]. eIF4E-IN-2 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. |
eIF4E-IN-3 |
|
HY-145309 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: eIF4E-IN-3 is a potent inhibitor of eukaryotic initiation factor 4e (eIF4e). eIF4E-IN-3 has the potential for researching eIF4e dependent diseases, including the research of cancer (extracted from patent WO2021003157A1, compound 485)[1]. |
eIF4E-IN-1 |
|
HY-145240 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: eIF4E-IN-1 is a potent inhibitor of eIF4E. eIF4E-IN-1 inhibits immunosuppression components such as immune checkpoint proteins PD-1, PD-L1, LAG3, TIM3, and/or IDO, in order to inhibit or release immune suppression in certain diseases, such as cancer and infectious disease (extracted from patent WO2021003194A1, compound Y)[1]. |
 eIF4E, GST-tag |
|
40530 |
BPS Bioscience |
100 µg |
EUR 425 |
|
Description: Human eIF4e (eukaryotic translation initiation factor 4E) (GenBank Accession No. NM_001968), a.a. 2-216 with N-terminal GST-tag, MW= 51 kDa, expressed in an E. coli expression system. |
 EIF4E Mouse mAb |
|
E2620407 |
EnoGene |
100ul |
EUR 225 |
|
Description: Available in various conjugation types. |
EIF4E Mouse mAb |
|
E2600167 |
EnoGene |
100ul |
EUR 225 |
|
Description: Available in various conjugation types. |
EIF4E Mouse mAb |
|
E2222620 |
EnoGene |
100ul |
EUR 255 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
) EIF4E siRNA (Rat) |
|
MBS8212162-15nmol |
MyBiosource |
15nmol |
EUR 405 |
EIF4E siRNA (Rat) |
|
MBS8212162-30nmol |
MyBiosource |
30nmol |
EUR 565 |
EIF4E siRNA (Rat) |
|
MBS8212162-5x30nmol |
MyBiosource |
5x30nmol |
EUR 2450 |
EIF4E Mouse mAb |
|
MBS8558662-01mL |
MyBiosource |
0.1mL |
EUR 305 |
EIF4E Mouse mAb |
|
MBS8558662-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 565 |
EIF4E Mouse mAb |
|
MBS8558662-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 565 |
EIF4E Mouse mAb |
|
MBS8558662-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 565 |
EIF4E Mouse mAb |
|
MBS8558662-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 565 |
EIF4E Mouse mAb |
|
MBS8550757-01mL |
MyBiosource |
0.1mL |
EUR 305 |
EIF4E Mouse mAb |
|
MBS8550757-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 565 |
EIF4E Mouse mAb |
|
MBS8550757-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 565 |
EIF4E Mouse mAb |
|
MBS8550757-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 565 |
EIF4E Mouse mAb |
|
MBS8550757-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 565 |
 eIF4E Mouse mAb |
|
A0467 |
Abclonal |
100μL |
EUR 262.15 |
A novel utility of MD following with the dynamical cross-correlation matrix (DCCM) evaluation instrument was used to determine putative protein domains to substantiate the steadiness of the expected mannequin and investigated the distinction of their dynamical conduct with the correlative fluctuations in movement.C-score in sufficient vary, the obtained fashions confirmed extra reliability.
The organic interpretation of the Viral Protein 2 of BTV was predicted DCCM maps had been calculated, every utilizing a unique coordinate reference body from which protein area boundaries and protein area residue constituents could possibly be recognized. Moreover, we anticipated that this analysis to play a promising function identification of novel candidate with the goal protein to inhibit their purposeful significance.
